Top Markets
Coin of the day
Chordia Therapeutics Inc. Chordia Therapeutics Inc.

Chordia Therapeutics Inc.

190A
Rank in Stocks #26480
Chordia Therapeutics Inc., a biotech company, engages in research and... Chordia Therapeutics Inc., a biotech company, engages in research and development of anti-cancer drugs that targets RNA deregulation stress in Japan. It develops CLK CTX-712, a CLK inhibitor, which is Phase 1 clinical trial for the treatment of relapsed or refractory malignant cancers.; CTX-177, a small-molecule inhibitor of MALT1; CDK12 inhibitor CTX-439; and GCN2 inhibitor CRD-1968099. Chordia Therapeutics Inc. was incorporated in 2017 and is based in Fujisawa, Japan.
Share Price
$0.53499835
Market Cap
$40.24M
Change (1 day)
2.50%
Change (1 year)
-58.07%
Country
JP
Trade Chordia Therapeutics Inc. (190A)

Category

Price of 190A with the market cap of B
Chordia Therapeutics Inc. Chordia Therapeutics Inc.
190A
$0.53499835
Market Capitalization of Chordia Therapeutics Inc.(190A)
Market Cap: $40.24M
As of August 2026 Chordia Therapeutics Inc. has a market cap of $40.24M. This makes Chordia Therapeutics Inc. the world's 26480th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Chordia Therapeutics Inc. from 2024 to 2026
190A compared with Top 5 Most Popular stocks
Price of 190A Asset B Mkt. of B Results
Chordia Therapeutics Inc. Chordia Therapeutics Inc.
$69,567.06 $40.24M
$5.233T +13,003,128.60%
Chordia Therapeutics Inc. Chordia Therapeutics Inc.
$61,802.32 $40.24M
$4.649T +11,551,771.44%
Chordia Therapeutics Inc. Chordia Therapeutics Inc.
$54,377.00 $40.24M
$4.090T +10,163,855.67%
Chordia Therapeutics Inc. Chordia Therapeutics Inc.
$47,513.04 $40.24M
$3.574T +8,880,869.31%
Chordia Therapeutics Inc. Chordia Therapeutics Inc.
$37,316.35 $40.24M
$2.807T +6,974,940.80%